Glycogen storage diseases: Diagnosis, treatment and outcome

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Translational Science of Rare Diseases

• Publication date

  2016-08-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/TRD-160006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome

  2016cited by this paper
• Safety and Efficacy of Long-Term Use of Extended Release Cornstarch Therapy for Glycogen Storage Disease Types 0, III, VI, and IX

  2016cited by this paper
• A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series

  2015cited by this paper
• Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib.

  2015cited by this paper
• Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.

  2015cited by this paper
• Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease.

  2015cited by this paper
• Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children

  2015cited by this paper
• Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

  2015cited by this paper
• Adult polyglucosan body disease

  2014cited by this paper
• Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

  2014cited by this paper
• The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.

  2014cited by this paper
• Pregnancy in Women With Glycogen Storage Disease Ia and Ib

  2014cited by this paper
• Aggressive therapy improves cirrhosis in glycogen storage disease type IX.

  2013cited by this paper
• Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants

  2012cited by this paper
• Bone mineral density in glycogen storage disease type Ia and Ib

  2012cited by this paper
• Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib

  2012cited by this paper
• Profile of patients with Von Gierke disease from India

  2012cited by this paper
• Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype.

  2012cited by this paper
• The genotype–phenotype correlation in Pompe disease

  2012cited by this paper
• Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

  2011cited by this paper
• Pompe disease gene therapy.

  2011cited by this paper
• Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.

  2011cited by this paper
• Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

  2011cited by this paper
• Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and Treatment

  2011influential reference
• Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies.

  2011cited by this paper
• Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder

  2010cited by this paper
• Glycogen Storage Disease Type III diagnosis and management guidelines

  2010cited by this paper
• Antibodies to CBir1 Are Associated With Glycogen Storage Disease Type Ib

  2010cited by this paper
• Hearing loss in Pompe disease revisited: results from a study of 24 children

  2010cited by this paper
• Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy.

  2009cited by this paper
• Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet

  2009cited by this paper
• Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation.

  2009cited by this paper
• Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.

  2009cited by this paper
• Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease

  2008cited by this paper
• Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease

  2008cited by this paper
• Et al

  2008cited by this paper
• Pompe's disease.

  2008cited by this paper
• Liver transplantation in children with glycogen storage disease: Controversies and evaluation of the risk/benefit of this procedure

  2008cited by this paper
• Identification of eight novel mutations of the acid α-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II

  2008cited by this paper
• Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.

  2008cited by this paper
• Tarui disease and distal glycogenoses: clinical and genetic update.

  2007cited by this paper
• Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype

  2007cited by this paper
• Muscle glycogenoses: an overview.

  2007influential reference
• High frequency of missense mutations in glycogen storage disease type VI

  2007cited by this paper
• Glycogen storage disease type IX: High variability in clinical phenotype.

  2007cited by this paper
• Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?

  2007cited by this paper
• McArdle disease: molecular genetic update.

  2007cited by this paper
• Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia.

  2006cited by this paper
• McArdle disease: the mutation spectrum of PYGM in a large Italian cohort

  2006cited by this paper
• Genetic risk factors associated with lipid‐lowering drug‐induced myopathies

  2006cited by this paper
• Pompe disease diagnosis and management guideline

  2006cited by this paper
• Ophthalmic manifestations of Danon disease.

  2006cited by this paper
• Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.

  2006cited by this paper
• Adult polyglucosan body disease: A case report of a manifesting heterozygote

  2005cited by this paper
• Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

  2005cited by this paper
• Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene

  2005cited by this paper
• Glucose-6-phosphatase and type 1 glycogen storage disease: Some critical considerations

  2005cited by this paper
• Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population

  2004cited by this paper
• Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse.

  2004cited by this paper
• Fatal infantile neuromuscular presentation of glycogen storage disease type IV.

  2004cited by this paper
• Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV)

  2004cited by this paper
• Twenty‐two novel mutations in the lysosomal α‐glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II

  2004cited by this paper
• A diagnostic cycle test for McArdle's disease

  2003cited by this paper
• Severe Phenotype of Phosphorylase Kinase-Deficient Liver Glycogenosis with Mutations in the PHKG2 Gene

  2003cited by this paper
• STRUCTURE OF GLYCOGENS AND AMYLOPECTINS

  2003cited by this paper
• Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases

  2003cited by this paper
• A neonatal form of glycogen storage disease type IV

  2003cited by this paper
• A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity.

  2003cited by this paper
• The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.

  2003cited by this paper
• Phenotype modulators in myophosphorylase deficiency

  2003cited by this paper
• Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport.

  2002cited by this paper
• The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.

  2002cited by this paper
• Phosphofructokinase deficiency; past, present and future.

  2002cited by this paper
• Clinicopathological features of genetically confirmed Danon disease

  2002cited by this paper
• Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.

  2002cited by this paper
• Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations.

  2002cited by this paper
• Case report: liver glycogen synthase deficiency--a cause of ketotic hypoglycemia.

  2001cited by this paper
• Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands

  2001cited by this paper
• Decreased urinary citrate excretion in type 1a glycogen storage disease.

  2001cited by this paper
• Molecular genetics of glycogen-storage disease type 1a in Chinese patients of Taiwan.

  2001cited by this paper
• Molecular heterogeneity of myophosphorylase deficiency (Mcardle's disease): A genotype‐phenotype correlation study

  2001cited by this paper
• The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome

  2001cited by this paper
• Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId

  2001cited by this paper
• How many forms of glycogen storage disease type I?

  2000cited by this paper
• Molecular analysis in glycogen storage disease 1 non‐A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients

  2000cited by this paper
• Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)

  2000cited by this paper
• Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease.

  2000cited by this paper
• Definition of the correct sequence in the donor splice site of intron 2 in the human glucose 6‐phosphate translocase gene

  1999cited by this paper
• The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a

  1999cited by this paper
• The Molecular Background of Glycogen Metabolism Disorders

  1999cited by this paper
• Complete genomic structure and mutational spectrum of PHKA2 in patients with x-linked liver glycogenosis type I and II.

  1999cited by this paper
• A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity.

  1999cited by this paper
• Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

  1998cited by this paper
• Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene

  1998cited by this paper
• A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.

  1998cited by this paper
• Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0.

  1998cited by this paper
• Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation.

  1998cited by this paper
• Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.

  1998cited by this paper
• Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis.

  1998cited by this paper
• Structure and mutation analysis of the glycogen storage disease type 1b gene

  1998cited by this paper

• Glycogénoses, hyperoxaluries, aminoacidopathies et hyperlipidémies : manifestations ostéoarticulaires

  2026cites this paper
• Inherited metabolic disorders: presentation, clinical types, laboratory diagnosis and genetic markers

  2025cites this paper
• Speckle Tracking Echocardiography for Early Detection of Myocardial Damage in Children with Glycogen Storage Diseases

  2025cites this paper
• Clinical and Genetic Profile of 35 Patients with Glycogen Storage Disease Type 1b: A Comparative Analysis Before and During SGLT2 Inhibitor Therapy

  2025cites this paper
• Feeding Difficulties in Children with Hepatic Glycogen Storage Diseases Identified by a Brazilian Portuguese Validated Screening Tool

  2025cites this paper
• Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

  2025cites this paper
• Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care

  2025cites this paper
• Glycogen storage disease type III: a mixed-methods study to assess the burden of disease

  2024cites this paper
• Report of an Iranian child with chronic abdominal pain and constipation diagnosed as glycogen storage disease type IX: a case report

  2024cites this paper
• Metabolic aspects of glycogenolysis with special attention to McArdle disease.

  2024cites this paper
• Medium-Chain Triglyceride Oil and Dietary Intervention Improved Body Composition and Metabolic Parameters in Children with Glycogen Storage Disease Type 1 in Jordan: A Clinical Trial

  2024cites this paper
• Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care

  2024cites this paper
• Anesthetic management of glycogen storage disease type 1b during liver transplantation: a case report

  2024cites this paper
• Co-occurrence of delayed language development and autism spectrum disorder in children with metabolic disorders

  2024cites this paper
• Nonfatal Isolated Cardiac Nonlysosomal Glycogenosis: A Rare Cause of Infantile Hypertrophic Cardiomyopathy

  2024cites this paper
• Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders

  2023cites this paper
• Clinical, biochemical and radiological findings in children with glycogen storage disease.

  2023cites this paper
• Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report

  2023cites this paper
• The multifaceted roles of the brain glycogen

  2023influential citation
• Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b

  2023cites this paper
• Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.

  2023cites this paper
• Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.

  2022cites this paper
• Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?

  2022cites this paper
• Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

  2022cites this paper
• Understanding hepatic Glycogen Storage Disease type Ia: role of phenotypic heterogeneity and nutrient sensors

  2022cites this paper
• In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues

  2022cites this paper
• Glycogen storage disease type 1a in the Ohio Amish

  2022cites this paper
• Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI

  2022cites this paper
• Diagnosis and follow‐up of glycogen storage disease (GSD) type VI from the largest GSD center in China

  2022cites this paper
• PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only

  2021influential citation
• Uncooked cornstarch for the prevention of hypoglycemic events

  2021cites this paper
• National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database

  2021cites this paper
• Hepatic adenomatosis in glycogen storage disease: Radio-pathological correlation.

  2021cites this paper
• Bone Mineral Density in Patients with Hepatic Glycogen Storage Diseases

  2021cites this paper
• Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy

  2021cites this paper
• Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs

  2021influential citation
• Over 20-Year Follow-up of Patients with Hepatic Glycogen Storage Diseases: Single-Center Experience

  2020cites this paper
• Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients

  2020cites this paper
• Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease

  2020cites this paper
• Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report

  2020cites this paper
• Combined liver-kidney transplantation for rare diseases

  2020cites this paper
• Rzadkie choroby metaboliczne - charakterystyka i dietoterapia

  2020cites this paper
• Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review

  2020cites this paper
• The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients

  2020cites this paper
• Three successful pregnancies in a patient with glycogen storage disease type 0

  2020cites this paper
• A novel recurrent 3.6-kb deletion in the PYGL gene contributes to glycogen storage disease type VI.

  2020cites this paper
• Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review

  2020cites this paper
• Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib

  2020influential citation
• Elevated Plasma Vitamin B12 in Patients with Hepatic Glycogen Storage Diseases

  2020cites this paper
• Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene

  2020cites this paper
• Protective and therapeutic effects of garlic and tomato on cadmium-induced neuropathology in mice

  2020cites this paper
• Hereditary muscle diseases and the heart: the cardiologist’s perspective

  2020influential citation
• Glycogen Storage Disease IXa in a 9-year-old Filipino Boy with Short Stature: A Case Report

  2020cites this paper
• Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III

  2019cites this paper
• Enzymes as Diagnostic Tools

  2019cites this paper
• A BEGINNERS’ GUIDE TO CORI’S DISEASE

  2019cites this paper
• Glycogen storage diseases-time to flip the outdated diagnostic approach centered on liver biopsy with the molecular testing

  2019cites this paper
• Ketogenic diet treatment in adults with glycogenosis type IIIa (Morbus Cori)

  2019cites this paper
• From the seminal discovery of proteoglycogen and glycogenin to emerging knowledge and research on glycogen biology.

  2019cites this paper
• Metabolic Control, Quality of Life, and Body Image in Patients with Glycogen Storage Disease Type Ia

  2019cites this paper
• Complex patterns of inheritance, including synergistic heterozygosity, in inborn errors of metabolism: Implications for precision medicine driven diagnosis and treatment.

  2019cites this paper
• Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children

  2019cites this paper
• Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis.

  2018cites this paper
• Inborn Errors of Metabolism with Hypoglycemia Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis

  2018cites this paper
• Non-alcoholic fatty liver disease caused by type IX glycogenosis - a series of cases in children

  2018cites this paper
• Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review.

  2018cites this paper
• Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia

  2018cites this paper
• Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control

  2017cites this paper
• Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy

  2017cites this paper
• First Case of Liver Glycogen Documented in the Pediatric Ward of the University Hospital of Treichville (Cote D’Ivoire)

  2017cites this paper